Last reviewed · How we verify
NCT04493112
SeQuent Please Neo Multicenter Registry
trial in Drug Coating Balloon (DCB), Sequent Please in 1,000 participants. Status unknown.
31 December 2021
Quick facts
| Lead sponsor | Germans Trias i Pujol Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 5 October 2018 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Spain |
Conditions studied
- Drug Coating Balloon (DCB), Sequent Please — all drugs for Drug Coating Balloon (DCB), Sequent Please →
Sponsor
Germans Trias i Pujol Hospital
Who can join
18 and older, any sex, with Drug Coating Balloon (DCB), Sequent Please. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The registry evaluates the safety and efficacy of paclitaxel-releasing SeQuent® Please Neo balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The objective is to determine the success of the procedure and the preservation of vascular permeability.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04493112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Germans Trias i Pujol Hospital trials
Trials by the same sponsor.
- NCT07064447 — Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator · not yet recruiting
- NCT06670547 — Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography · not yet recruiting
- NCT06337539 — Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants · not yet recruiting
- NCT07009054 — Program for the Promotion of Physical Exercise and Healthy Eating Among Population of Pakistani Origin With Obesity · NA · completed
- NCT07386275 — Impact of the eSalut Program in Hospital-at-Home (HOMeSALUT) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04493112 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Germans Trias i Pujol Hospital
- Last refreshed: 30 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04493112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing